echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Researchers have discovered a new role in acute myeloid leukemia

    Researchers have discovered a new role in acute myeloid leukemia

    • Last Update: 2021-09-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Picture: Ze'ev Ronai is the director of the Sanford Burnham prebyys cancer center designated by nci

    Source: Sanford Burnham prebyys

    A new study led by scientists at Sanford Burnham Prebis University shows that the protein RNF5 plays an unusual role in acute myeloid leukemia (AML)


    "AML cells are highly dependent on the RNF5 protein," said Dr.


    Ronai's laboratory has been researching RNF5 for 10 years, mainly in breast and skin cancer, and is curious about its role in acute myeloid leukemia, because patients with acute myeloid leukemia have high RNF5 levels often prognosis Bad


    Under normal circumstances, as a ubiquitin ligase, RNF5 helps mark other proteins for destruction


    "We were very surprised to find that ubiquitin ligase actually regulates gene transcription in AML," said Dr.


    The team continues to accumulate evidence that RNF5 and RBBP4 jointly promote AML


    These findings may have some therapeutic results


    Ronai said: "Patients with lower levels of RNF5 or RBBP4 may respond better to HDAC inhibitors


    DOI

    10.


    RNF5 Regulation of RBBP4 Determines Acute Myeloid Leukemia Growth and Susceptibility to Histone Deacetylase Inhibitors



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.